Patents by Inventor Meenakshi S. Venkatraman

Meenakshi S. Venkatraman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20240124385
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: November 21, 2023
    Publication date: April 18, 2024
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Treprostinil derivative compounds and methods of using same
    Patent number: 11958822
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: October 14, 2022
    Date of Patent: April 16, 2024
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang, Jürg R. Pfister, Gwenaella Rescourio
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20240116847
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: September 20, 2023
    Publication date: April 11, 2024
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 11866402
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: April 30, 2021
    Date of Patent: January 9, 2024
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • ORAL PYROPHOSPHATE FOR USE IN REDUCING CALCIFICATION
    Publication number: 20230381223
    Abstract: The current invention relates to use of oral pyrophosphate wherein said pyrophosphate is selected from the group consisting of monoarginine pyrophosphate, monolysine pyrophosphate, dipotassium pyrophosphate, bisethanolamine pyrophosphate and bisammonium pyrophosphate for preventing and/or reducing tissue calcification, particularly soft tissue calcification, and/or diseases or disorders characterized by low plasma PPi levels, as, e.g.
    Type: Application
    Filed: October 14, 2021
    Publication date: November 30, 2023
    Inventors: Donald A. McCarthy, Jim W. Larrick, Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang, Viola Pomozi, András VÁRADI
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 11802105
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: October 31, 2023
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20230331691
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: October 14, 2022
    Publication date: October 19, 2023
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS
    Publication number: 20230130425
    Abstract: The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.
    Type: Application
    Filed: September 19, 2022
    Publication date: April 27, 2023
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG, James W. LARRICK
  • Treprostinil derivative compounds and methods of using same
    Patent number: 11505535
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: November 22, 2022
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20220363626
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: June 29, 2022
    Publication date: November 17, 2022
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Aminoadamantyl nitrate compounds and their use to treat CNS disorders
    Patent number: 11447442
    Abstract: The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: September 20, 2022
    Assignee: Panorama Research, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang, James W. Larrick
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 11407707
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: August 9, 2022
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Treprostinil derivative compounds and methods of using same
    Patent number: 11339139
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: July 13, 2020
    Date of Patent: May 24, 2022
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20220112173
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: March 26, 2021
    Publication date: April 14, 2022
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20220055980
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: March 22, 2021
    Publication date: February 24, 2022
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20210355072
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: April 30, 2021
    Publication date: November 18, 2021
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Treprostinil derivative compounds and methods of using same
    Patent number: 11046666
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: June 29, 2021
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 11034645
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: June 15, 2021
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 10988435
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: April 27, 2021
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20210009501
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: July 22, 2020
    Publication date: January 14, 2021
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER